Anresco Laboratories and NJ Labs have joined forces to establish Anresco NJ Labs, a nationwide network uniting trusted, compliant and independent testing solutions across multiple regulated industries.
The partnership will be officially introduced at SupplySide Global, taking place October 27-30 in Las Vegas at Mandalay Bay Convention Center (booth 7927).
Anresco NJ Labs offers a unified, nationwide testing service that leverages shared methods, quality systems and innovation to meet the evolving regulatory needs of manufacturers, brands and distributors across food, cannabis, dietary supplement, pharmaceutical, chemical and personal care sectors.
“By aligning our laboratories, we’re providing clients with a trusted and accessible nationwide network that ensures faster turnaround times, consistent results and transparent reporting,” said Sandra Lee, CEO of NJ Labs.
“Our shared mission is to simplify compliance and empower companies to bring safe, high-quality products to market with confidence.”
Anresco NJ Labs will operate under strict ISO/IEC 17025:2017 accreditation and FDA, USDA, USP, CGMP and DEA regulatory frameworks.
It will integrate scientific expertise and validated testing methods for everything from active ingredients and contaminants to cannabinoid profiles, pathogens and shelf-life studies.
The partnership also leverages digital reporting and client portal systems for efficiency and accessibility.
“Our collaboration brings together two independent laboratories with a shared commitment to scientific integrity, innovation and quality,” said Zachary Eisenberg, Vice President of Anresco Laboratories.
“By uniting our complementary expertise and expanding our geographic reach, we’re able to offer clients broader capabilities and more efficient service across multiple locations."
"This partnership strengthens our ability to deliver accurate, timely and science-driven solutions that meet the highest standards of the industries we serve.”